Comparison of risk factors for seropositivity to feline immunodeficiency virus and feline leukemia virus among cats: a case-case study

BMC Veterinary Research

Dorothee Bienzle¹  David L Pearl²  Olaf Berke³  Bimal K Chhetri² 

[1] Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada;Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada;Institute of Biometry, Epidemiology and Information Processing, University of Veterinary Medicine Hanover (Foundation), Hanover, Germany

关键词: FeLV;    FIV;    Retrovirus;    Epidemiology;    Cat;   

Others  :  1131407
DOI  :  10.1186/s12917-015-0339-3

 received in 2014-05-30, accepted in 2015-01-22,  发布年份 2015

【 摘 要 】

Background

Feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV) are reported to have similar risk factors and similar recommendations apply to manage infected cats. However, some contrasting evidence exists in the literature with regard to commonly reported risk factors. In this study, we investigated whether the known risk factors for FIV and FeLV infections have a stronger effect for either infection. This retrospective study included samples from 696 cats seropositive for FIV and 593 cats seropositive for FeLV from the United States and Canada. Data were collected during two cross sectional studies, where cats were tested using IDEXX FIV/FeLV ELISA kits. To compare the effect of known risk factors for FIV infection compared to FeLV, using a case-case study design, random intercept logistic regression models were fit including cats’ age, sex, neuter status, outdoor exposure, health status and type of testing facility as independent variables. A random intercept for testing facility was included to account for clustering expected in testing practices at the individual clinics and shelters.

Results

In the multivariable random intercept model, the odds of FIV compared to FeLV positive ELISA results were greater for adults (OR = 2.09, CI: 1.50-2.92), intact males (OR = 3.14, CI: 1.85-3.76), neutered males (OR = 2.68, CI: 1.44- 3.14), cats with outdoor access (OR = 2.58, CI: 1.85-3.76) and lower for cats with clinical illness (OR = 0.60, 95% CI: 0.52-0.90). The variance components obtained from the model indicated clustering at the testing facility level.

Conclusions

Risk factors that have a greater effect on FIV seropositivity include adulthood, being male (neutered or not) and having access to outdoors, while clinical illness was a stronger predictor for FeLV seropositivity. Further studies are warranted to assess the implications of these results for the management and control of these infections.

【 授权许可】

   
2015 Chhetri et al.; licensee BioMed Central.

【 参考文献 】

• [1]Levy JK, Scott HM, Lachtara JL, Crawford PC: Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity. J Am Vet Med Assoc 2006, 228(3):371-6.
• [2]Little S, Bienzle D, Carioto L, Chisholm H, O’Brien E, Scherk M: Feline leukemia virus and feline immunodeficiency virus in Canada: recommendations for testing and management. Can Vet J 2011, 52(8):849-55.
• [3]Levy J: Feline leukemia virus and feline immunodeficiency virus. In Infectious disease management in animal shelters. Edited by Miller L, Hurley K, Hoboken F. Wiley-Blackwell, NJ, USA; 2009:307-17.
• [4]Sellon RK, Hartmann K: Feline immunodeficiency virus infection. In Infectious diseases of the dog and cat. 3rd edition. Edited by Greene CE. Elsevier, Philadelphia, USA; 2006:131-42.
• [5]Levy J, Crawford C, Hartmann K, Hofmann-Lehmann R, Little S, Sundahl E, et al.: 2008 American Association of Feline Practitioners’ feline retrovirus management guidelines. J Feline Med Surg 2008, 10(3):300-16.
• [6]Hoover EA, Olsen RG, Hardy WD, Schaller JP, Mathes LE: Feline leukemia virus infection: age-related variation in response of cats to experimental infection. J Nat Cancer Inst 1976, 57(2):365-9.
• [7]Little S, Sears W, Lachtara J, Bienzle D: Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in Canada. Can Vet J 2009, 50(6):644-8.
• [8]Goldkamp CE, Levy JK, Edinboro CH, Lachtara JL: Seroprevalences of feline leukemia virus and feline immunodeficiency virus in cats with abscesses or bite wounds and rate of veterinarian compliance with current guidelines for retrovirus testing. J Am Vet Med Assoc 2008, 232(8):1152-8.
• [9]Gleich SE, Krieger S, Hartmann K: Prevalence of feline immunodeficiency virus and feline leukaemia virus among client-owned cats and risk factors for infection in Germany. J Feline Med Surg 2009, 11(12):985-92.
• [10]Dohoo IR, Martin W, Stryhn H: Veterinary Epidemiologic Research. Charlottetown, AVC Inc; 2009.
• [11]McCarthy N, Giesecke J: Case-case comparisons to study causation of common infectious diseases. Int J Epidemiol 1999, 28(4):764-8.
• [12]Wilson N, Baker M, Edwards R, Simmons G: Case-case analysis of enteric diseases with routine surveillance data: Potential use and example results. Epidemiol Perspect Innov 2008, 5:6. BioMed Central Full Text
• [13]Twisk JWR: Applied multilevel analysis : a practical guide. Cambridge University Press, Cambridge, UK; New York; 2006.
• [14]R Development Core Team: R: a language and environment for statistical computing R Foundation for Statistical Computing, Vienna, Austria 2011. ISBN 3-900051-07-0
• [15]StataCorp: Stata Statistical Software: Release 11. StataCorp LP, College Station, TX; 2009.
• [16]Yamamoto JK, Hansen H, Ho EW, Morishita TY, Okuda T, Sawa TR, et al.: Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J Am Vet Med Assoc 1989, 194(2):213-20.
• [17]Dunham SP, Graham E: Retroviral infections of small animals. Vet Clin North Am Small Anim Pract 2008, 38(4):879-901.
• [18]Allison RW, Hoover EA: Feline immunodeficiency virus is concentrated in milk early in lactation. AIDS Res Hum Retroviruses 2003, 19(3):245-53.
• [19]Jarrett O, Hardy WD, Golder MC, Hay D: The frequency of occurrence of feline leukaemia virus subgroups in cats. Int J Cancer 1978, 21(3):334-7.
• [20]Jarrett O, Golder MC, Stewart MF: Detection of transient and persistent feline leukaemia virus infections. Vet Rec 1982, 110(10):225-8.
• [21]Jarrett WF, Martin WB, Crighton GW, Dalton RG, Stewart MF: Transmission Experiments with Leukemia (Lymphosarcoma). Nature 1964, 202:566-7.
• [22]Jarrett WF, Crawford EM, Martin WB, Davie F: A Virus-Like Particle Associated with Leukemia (Lymphosarcoma). Nature 1964, 202:567-9.
• [23]Grant CK, Essex M, Gardner MB, Hardy WD Jr: Natural feline leukemia virus infection and the immune response of cats of different ages. Cancer Res 1980, 40(3):823-9.
• [24]Essex M, Cotter S, Sliski A, Hardy W Jr, Stephenson J, Aaronson S, et al.: Horizontal transmission of feline leukemia virus under natural conditions in a feline leukemia cluster household. Int J Cancer 1977, 19(1):90-6.
• [25]Addie DD, Dennis JM, Toth S, Callanan JJ, Reid S, Jarrett O: Long-term impact on a closed household of pet cats of natural infection with feline coronavirus, feline leukaemia virus and feline immunodeficiency virus. Vet Rec 2000, 146(15):419-24.
• [26]Hartmann K: Clinical aspects of feline immunodeficiency and feline leukemia virus infection. Vet Immunol Immunopathol 2011, 143(3–4):190-201.
• [27]Hitt ME, Spangler L, McCarville C: Prevalence of feline immunodeficiency virus in submissions of feline serum to a diagnostic laboratory in Atlantic Canada. Can Vet J 1992, 33(11):723-6.
• [28]Lee IT, Levy JK, Gorman SP, Crawford PC, Slater MR: Prevalence of feline leukemia virus infection and serum antibodies against feline immunodeficiency virus in unowned free-roaming cats. J Am Vet Med Assoc 2002, 220(5):620-2.
• [29]Ishida T, Washizu T, Toriyabe K, Motoyoshi S, Tomoda I, Pedersen NC: Feline immunodeficiency virus infection in cats of Japan. J Am Vet Med Assoc 1989, 194(2):221-5.
• [30]Spada E, Proverbio D, dellaPepa A, Perego R, Baggiani L, DeGiorgi GB, et al.: Seroprevalence of feline immunodeficiency virus, feline leukaemia virus and Toxoplasma gondii in stray cat colonies in northern Italy and correlation with clinical and laboratory data. J Feline Med Surg 2012, 14(6):369-77.
• [31]O’Connor TP Jr, Tonelli QJ, Scarlett JM: Report of the national FeLV/FIV awareness project. J Am Vet Med Assoc 1991, 199(10):1348-53.
• [32]Shelton GH, Waltier RM, Connor SC, Grant CK: Prevalence of feline immunodeficiency virus and feline leukemia-virus infections in pet cats. J Am Anim Hosp Assoc 1989, 25(1):7-12.
• [33]Cohen ND, Carter CN, Thomas MA, Lester TL, Eugster AK: Epizootiologic association between feline immunodeficiency virus-infection and feline leukemia-virus seropositivity. J Am Vet Med Assoc 1990, 197(2):220-5.
• [34]Grindem CB, Corbett WT, Ammerman BE, Tomkins MT: Seroepidemiologic survey of feline immunodeficiency virus infection in cats of Wake County, North Carolina. J Am Vet Med Assoc 1989, 194(2):226-8.
• [35]Sukura A, Grohn YT, Junttila J, Palolahti T: Association between feline immunodeficiency virus antibodies and host characteristics in Finnish cats. Acta Vet Scand 1992, 33(4):325-34.
• [36]Ueland K, Lutz H: Prevalence of feline leukemia-virus and antibodies to feline immunodeficiency virus in cats in Norway. J Vet Med Ser B-Infectious Dis Vet Public Health 1992, 39(1):53-8.
• [37]Akhtardanesh B, Ziaali N, Sharifi H, Rezaei S: Feline immunodeficiency virus, feline leukemia virus and Toxoplasma gondii in stray and household cats in Kerman-Iran: seroprevalence and correlation with clinical and laboratory findings. Res Vet Sci 2010, 89(2):306-10.
• [38]Muirden A: Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus and feline coronavirus in stray cats sent to an RSPCA hospital. Vet Rec 2002, 150(20):621-5.
• [39]Ravi M, Wobeser GA, Taylor SM, Jackson ML: Naturally acquired feline immunodeficiency virus (FIV) infection in cats from western Canada: prevalence, disease associations, and survival analysis. Can Vet J 2010, 51(3):271-6.
• [40]Yilmaz H, Ilgaz A, Harbour DA: Prevalence of FIV and FeLV infections in cats in Istanbul. J Feline Med Surg. 2000, 2(1):69-70.
• [41]Hosie MJ, Addie D, Belak S, Boucraut-Baralon C, Egberink H, Frymus T, et al.: Feline immunodeficiency. ABCD guidelines on prevention and management. J Feline Med Surg 2009, 11(7):575-84.
• [42]Pogreba-Brown K, Ernst K, Harris RB: Case-case methods for studying enteric diseases: a review and approach for standardization. OA Epidemiol 2014, 2(1):7.
• [43]Martínez ME, Cruz GI, Brewster AM, Bondy ML, Thompson PA: What can we learn about disease etiology from case-case analyses? Lessons from breast cancer. Cancer Epidemiol Biomarkers Prev 2010, 19(11):2710-4.